Back to catalogue
№ 263 33 filings · 2021-09-27 → 2026-07-08

NORMAN BROADBENT PLC

NBB
Industrial Goods and Services Share price 204p Market cap £3.95m Overall fit 300 /1000

Statistically very cheap and cash-backed, but essentially zero direct AI-receiver exposure and services-business operating leverage is modest — a value idea, not a fit for the AI/operating-leverage thesis this investor is running.

Fair value range 300p–450p Mid case · £7.20m
Absolute upside +82.1% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • clean audited numbers
  • fortress balance sheet with £1.5m net cash
  • multiple valuation methods agree stock is cheap
Limits the call
  • AIM micro-cap illiquidity widens the fair-value range
  • H1 26 softness threatens FY26 £13.1m NFI consensus
Methodology

Blend of EV/EBITDA (4-6x) and P/E (8-12x) on FY25 delivered earnings, cross-checked against net cash

In one line · bull case

AIM micro-cap executive search firm trading at ~1.6x EV/EBITDA and ~5.9x earnings with £1.5m net cash after a successful four-year organic turnaround.

In one line · biggest risk

Executive-search cyclicality plus AI substitution risk in the research function — H1 26 already softening from a record 2025.

Drivers
AI beneficiary 20 /100
Executive search is exposed to AI substitution in research/candidate mapping; NBB adopts AI tools (AssessioAI) but captures none of that value — it is a spender, not receiver.
Operating leverage 55 /100
Moderate: FY25 33% NFI growth delivered 333% EBITDA growth (~33% incremental margin), but staff cost is largely variable via bonuses; not software-like leverage.
Earnings vs expectations 70 /100
FY25 came in comfortably ahead of Board expectations; medium-term EBITDA target hit a year early; consistent beats since 2022 turnaround.
Growth momentum 55 /100
FY25 NFI +32%, but Q1 26 down 27% YoY and H1 26 down 12% YoY — momentum has stalled at the top of the cycle.
Moat 30 /100
Brand heritage (est. 1979) has value but no structural switching costs or network effects; recovering from prior brand deterioration.
Earnings quality 70 /100
Clean: FY25 EBITDA £1.3m converted to £1.9m operating cash; 42-day debtor days; no aggressive accounting flagged.
Management quality 65 /100
Davidson/Malik team delivered planned four-year turnaround from £0.7m net debt to £1.5m net cash and doubled NFI in a shrinking market.
Cyclicality 75 /100
Executive search is deeply cyclical, tied to CEO/board hiring confidence; H1 26 already shows sensitivity to geopolitical uncertainty.
Leverage 10 /100
Net cash £1.5m, CBILS loan fully repaid April 2025, invoice discounting facility undrawn — fortress balance sheet for a company this size.
Value-trap signals · 4
  • repeated share consolidations (70-for-2 in 2025)
  • historic P&L deficit of £18.5m being cleared via capital reorganisation
  • two NEDs departing simultaneously Q1 2026
  • AIM micro-cap illiquidity — 1.9m shares in issue

Norman Broadbent PLC (NBB.L) — Investment Research Note

Executive summary

Norman Broadbent is a UK-listed executive search and senior interim management firm (est. 1979) that has just completed a four-year organic turnaround, taking NFI from £5.9m in 2021 to £12.3m in FY25 with underlying EBITDA of £1.3m and net cash of £1.5m 2026-03-25 final results. Operating trajectory has been sharply positive under CEO Kevin Davidson but H1 26 NFI at £5.3m is down on a record £6.0m H1 25 comp, with management pointing to macro/geopolitical friction and forecast NFI of £13.1m for FY26 2026-07-08 H1 26 update; 2026-05-20 AGM. The single most important valuation point today: the shares trade at ~1.6x EV/EBITDA and ~5.9x FY25 earnings against a business that has just doubled NFI, sits on net cash, and has £15.6m of usable tax losses — the market is pricing this as a distressed micro-cap despite delivering the strongest performance in over a decade.

Fair value estimate

  • Fair value range: 300p – 450p per share, implying market cap of £5.8m – £8.7m.
  • Methodology: blended EV/EBITDA and P/E on FY25 delivered numbers (I explicitly do not extrapolate the FY26 £13.1m NFI target given H1 26 softness).
    • EV/EBITDA: apply 4–6x to FY25 underlying EBITDA of £1.3m = £5.2m–£7.8m EV, plus £1.5m net cash = £6.7m–£9.3m market cap. UK-listed recruiters typically trade 6–10x through-cycle; a 4–6x range reflects micro-cap illiquidity, AIM discount, and cyclical risk.
    • P/E: apply 8–12x to FY25 basic EPS of 31.9p = 255p–383p per share. NBB pays no tax due to £15.6m carried-forward trading losses (deferred tax asset unrecognised), so headline EPS is understated relative to a fully taxed peer.
    • Sense-check: FY25 net cash of £1.5m alone equals ~41% of the current £3.6m market cap; the operating business is being valued at ~£2.1m EV, i.e. ~2x EBITDA and less than 0.2x NFI.
  • Current market cap: £3.6m (187.50p × 1.926m shares).
  • Absolute upside to mid-point of 375p: +100%. Range implies +60% to +140%.

Sector context

  • Confirmed classification: Industrials → Industrial Goods & Services → Employment/Professional Services. NBB self-describes as professional services (executive search, interim management, leadership advisory).
  • Profile vs peers: below-typical in scale, above-typical in balance-sheet cleanliness (net cash, no bank debt post-CBILS repayment in April 2025), in line on gross-margin structure. Growth in FY25 (+32% NFI) was materially above the recruitment sector, which has broadly been in contraction. Quality-wise, mid-tier — brand heritage is a genuine asset but the business lacks the scale of tier-1 global peers.
  • Listed peers: PageGroup (PAGE), Robert Walters (RWA), Hays (HAS) at the large end; SThree (STEM), Empresaria (EMR), Gattaca (GATC), Staffline (STAF) at the small end. NBB is by an order of magnitude the smallest by market cap.

Investment thesis

  • Deep-value micro-cap post-turnaround. Company has hit its four-year EBITDA target of £1.25m one year early, cleared debt, and generated £1.9m of operating cash in FY25, all against a shrinking wider recruitment market 2026-03-25 final results. At ~1.6x EV/EBITDA and a market cap that is only 2.4x FY25 EBITDA, valuation offers a meaningful margin of safety.
  • Optionality on operational scaling and the new capital reorganisation. Board has proposed cancelling deferred shares and share premium to eliminate the historic P&L deficit and re-create distributable reserves, opening the door to future dividends 2026-03-25 final results, post-year-end events. Combined with the Society Limited acquisition (Feb 2026) and hires of seven net fee-earners across H1 26, there are visible growth levers 2026-07-08 H1 26 update.
  • Fortress balance sheet with real tax shield. Net cash of £1.5m at year-end (vs £3.6m market cap), no interest-bearing loans, invoice discounting facility undrawn, and £15.6m of unrecognised trading losses that will shelter UK profits for years 2026-03-25 final results, note 6.

Key risks

  • Cyclicality and single-market concentration. Executive search is deeply cyclical and NBB is heavily UK-weighted (65% of revenue). H1 26 NFI down 12% YoY already signals the FY26 £13.1m NFI consensus is at risk 2026-07-08 H1 26 update.
  • AI disruption to the research function. In-house research/insight — historically the labour-intensive core of executive search — is exactly the kind of work AI agents can compress. Management is adopting AI (AssessioAI, client portal) but is a user, not a seller, of AI 2026-03-25 final results.
  • Micro-cap governance & liquidity risk. Two independent NEDs (Kempster and Vaishampayan) both departing in early 2026, only 1.9m shares in issue after 70:2 consolidation, and £3.6m market cap makes the stock effectively uninvestable for institutions and vulnerable to sentiment shocks 2026-03-25 final results, Chair's statement.

Operating leverage

NBB has moderate operating leverage. The cost base is dominated by employee remuneration (£9.6m out of £11.6m of FY25 opex, or ~83%), but a material portion is variable — bonuses tied directly to fee generation. Fixed costs are meaningfully lower: lease liabilities of only £0.18m, minimal depreciation (£0.4m). What creates leverage is that (i) research/insight headcount can support 1.7-2.0 fee-earners each (up from 1.4 in 2022), (ii) recent NFI growth of 32% in FY25 delivered a 333% EBITDA increase — an incremental EBITDA margin of ~33% on marginal NFI, and (iii) the £15.6m tax loss shields incremental profit fully. If FY26 NFI hit £13.1m (mgmt target) and incremental drop-through of 30-35% held, EBITDA could reach ~£1.6-1.8m vs £1.3m — a ~25-40% uplift on ~7% NFI growth. But this is services leverage, not software leverage: gross margins are 81%, not 90%+, and any NFI beat requires more people 2026-03-25 final results, income statement & note 5.

Value-trap signals

  • Repeated share consolidations to prop up penny-share status (70-for-2 in May 2025); historic deficit of £18.5m still on the balance sheet.
  • Long-running loss-making history: £15.6m of trading losses carried forward reflects over a decade of underperformance.
  • Two NEDs departing simultaneously in Q1 2026 — worth watching but not clearly indicative of a governance problem.
  • AIM micro-cap liquidity: only 1.9m shares in issue; typical daily volume is negligible.
  • These are legitimate concerns but not classic terminal-decline signals; the operating turnaround is genuine and independently verifiable in the accounts.

Earnings vs expectations

Where guidance was set, NBB has generally beaten or met it. FY25 EBITDA of £1.3m came in "comfortably ahead of Board expectations" per January 2026 pre-close 2026-01-15 Q4 25 update. The medium-term £1.25m EBITDA target set in 2021 was delivered a year early. Q1 26 (NFI £2.2m vs £3.0m Q1 25) was flagged as reflecting the strong FY25 close pulling forward, and management "reiterated" FY26 expectations at the May AGM and again in July 2026-04-21 Q1 26 update; 2026-05-20 AGM; 2026-07-08 H1 26 update. Analyst consensus of £13.1m FY26 NFI is a stretch given H1 26 delivered £5.3m — implying H2 needs £7.8m, which would be a record. Pattern: consistent beats since 2022, but the FY26 consensus now looks demanding after a soft H1.

Conviction: 3 (moderate)

Anchors: clean audited accounts with straightforward P&L; fortress balance sheet is unambiguous (£1.5m net cash confirmed); multiple valuation approaches (EV/EBITDA, P/E, book value + cash) all agree the shares are cheap on delivered numbers.

Caveats: valuing a £3.6m AIM micro-cap involves a wide range — precise fair-value point is genuinely uncertain given illiquidity and cyclicality; H1 26 downtick creates real doubt over the FY26 £13.1m NFI trajectory that underpins the more optimistic end of my range.


Filings consulted · 42

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-08H1 2026 Trading Update2026-07-08_9657166_h1-2026-trading-update.md0.85
  2. 2026-05-20Result OF Agm2026-05-20_9577833_result-of-agm.md0.30
  3. 2026-05-20Agm Statement2026-05-20_9576506_agm-statement.md0.40
  4. 2026-04-22Posting OF Annual Report Amp Notice OF Agm2026-04-22_9531486_posting-of-annual-report-amp-notice-of-agm.md0.95
  5. 2026-04-21Q1 2026 Trading Update2026-04-21_9529266_q1-2026-trading-update.md0.85
  6. 2026-03-25Final Results2026-03-25_9490308_final-results.md1.00
  7. 2026-03-09Replacement Results Notice Investor Presentation2026-03-09_9464703_replacement-results-notice-investor-presentation.md0.70
  8. 2026-03-09Notice OF Interim Results Amp Investor Presentation2026-03-09_9463730_notice-of-interim-results-amp-investor-presentation.md0.90
  9. 2026-01-15Q4 And Fy25 Trading Update2026-01-15_9354425_q4-and-fy25-trading-update.md0.72
  10. 2025-10-13Q3 2025 Trading Update2025-10-13_9165975_q3-2025-trading-update.md0.72
  11. 2025-09-08Interim Results2025-09-08_9092082_interim-results.md0.77
  12. 2025-08-19Notice OF Interim Results Amp Investor Presentation2025-08-19_9062438_notice-of-interim-results-amp-investor-presentation.md0.77
  13. 2025-07-10H1 2025 Trading Update2025-07-10_8972154_h1-2025-trading-update.md0.55
  14. 2025-05-22Result OF Agm Capital Reorganisation And Tvr2025-05-22_8893020_result-of-agm-capital-reorganisation-and-tvr.md0.20
  15. 2025-05-22Agm Statement2025-05-22_8891221_agm-statement.md0.26
  16. 2025-04-22Posting OF Ara Amp Notice OF Agm2025-04-22_8838220_posting-of-ara-amp-notice-of-agm.md0.20
  17. 2025-04-02Q1 2025 Trading Update And Final Results2025-04-02_8809268_q1-2025-trading-update-and-final-results.md0.65
  18. 2025-03-04Notice OF Results Amp Investor Presentation2025-03-04_8761413_notice-of-results-amp-investor-presentation.md0.46
  19. 2025-01-16Trading Update2025-01-16_8690961_trading-update.md0.55
  20. 2024-10-16Q3 2024 Trading Update2024-10-16_8488385_q3-2024-trading-update.md0.55
  21. 2024-09-09Interim Results2024-09-09_8405281_interim-results.md0.58
  22. 2024-08-19Notice OF Interim Results Amp Investor Presentation2024-08-19_8372165_notice-of-interim-results-amp-investor-presentation.md0.58
  23. 2024-07-11H1 2024 Trading Update2024-07-11_8305243_h1-2024-trading-update.md0.38
  24. 2024-04-25Q1 2024 Trading Update2024-04-25_8155645_q1-2024-trading-update.md0.38
  25. 2024-03-28Posting OF Ara Amp Notice OF Agm2024-03-28_8111166_posting-of-ara-amp-notice-of-agm.md0.14
  26. 2024-03-27Final Results2024-03-27_8108576_final-results.md0.45
  27. 2024-03-20Notice OF Results Amp Investor Presentation2024-03-20_8098282_notice-of-results-amp-investor-presentation.md0.32
  28. 2024-01-16Trading Update2024-01-16_7990485_trading-update.md0.38
  29. 2023-10-12Q3 2023 Trading Update2023-10-12_7811338_q3-2023-trading-update.md0.38
  30. 2023-07-24Interim Results2023-07-24_7649533_interim-results.md0.23
  31. 2023-07-11H1 2023 Trading Update2023-07-11_7624283_h1-2023-trading-update.md0.21
  32. 2023-06-29Result OF Agm2023-06-29_7603798_result-of-agm.md0.07
  33. 2023-06-05Posting OF Annual Report And Notice OF Agm2023-06-05_7558483_posting-of-annual-report-and-notice-of-agm.md0.24
  34. 2023-05-31Final Results2023-05-31_7551514_final-results.md0.25
  35. 2023-05-22Q1 2023 Trading Update2023-05-22_7535415_q1-2023-trading-update.md0.21
  36. 2023-01-24Trading Update2023-01-24_7499652_trading-update.md0.21
  37. 2022-08-16Interim Results2022-08-16_7101834_interim-results.md0.23
  38. 2022-07-11Trading Update2022-07-11_6923281_trading-update.md0.21
  39. 2022-06-23Result OF Agm2022-06-23_7068703_result-of-agm.md0.07
  40. 2022-05-25Final 2021 Results And Notice OF Agm2022-05-25_6977313_final-2021-results-and-notice-of-agm.md0.07
  41. 2022-03-02Fy2021 Trading Update2022-03-02_6964477_fy2021-trading-update.md0.21
  42. 2021-09-27Interim Results For Six Months Ended 30 June 20212021-09-27_6561116_interim-results-for-six-months-ended-30-june-2021.md0.23

This research note was authored by a large language model after reading 33 regulatory filings published between 2021-09-27 and 2026-07-08. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.